logo

HomeArticlesServicePriceAbout

Menu

Home
Articles
Service
Price
Search
About
logo
logo

Company

AboutTerms of Service Privacy Policy

Social

LinkedIn Twitter Discord

Contact

contact@coresixteen.com coresixteen.com
Company NameCORE16 Inc.
CEODavid Cho
Business Registration Number762-81-03235
officePhone070-4225-0201
Address83, Uisadang-daero, Yeongdeungpo-gu, Seoul, 07325, Republic of KOREA

Test1

article
박재훈투영인 프로필 사진박재훈투영인
Buy the Second-Best Stock (May 14, 2025)
created At: 5/15/2025
Neutral
Neutral
This analysis was written from a neutral perspective. We advise you to always make careful and well-informed investment decisions.
TSLA
Tesla
ABBV
AbbVie
6
0
0
Fact
-AMD rose 4% after announcing a $6 billion share buyback; Nations recommends a “Buy.” -AMD is trading 35% below its 52-week high, despite gaining 25% over the past month. -AbbVie was downgraded by Citi, but Nations maintains a “Buy” rating. -Tesla gained 4% following reports it resumed importing EV components from China; Nations rates the stock as “Hold.” -Tesla still faces potential risks from renewed Chinese tariff hikes.
Opinion
-Scott Nations remains optimistic about AMD and AbbVie, citing strong fundamentals and long-term growth potential despite recent negative headlines. -For AMD, Nations sees AI infrastructure investment, share buybacks, and potential easing of export restrictions as key upside drivers. -Despite Citi’s downgrade, Nations views AbbVie’s consistent earnings beats, dividend growth, and 3.5% yield as strong reasons to stay bullish. -Tesla’s short-term upside from supply chain normalization is offset by tariff uncertainty, especially given the potential for rates to triple within three months.
Core Sell Point
Nations sees AMD and AbbVie as strong buy candidates driven by fundamentals and strategic positioning. Tesla remains a “Hold,” as tariff risks may cap its upside despite recent gains.

According to Scott Nations, president of Nations Indexes, investors should consider taking a bullish stance on Advanced Micro Devices (AMD) following a series of positive headlines surrounding the stock. Appearing on CNBC’s “Power Lunch” on Wednesday, Nations also discussed two of the day’s biggest stock stories and shared whether investors should consider buying or selling those names.

Advanced Micro Devices

Shares of the AI chipmaker jumped more than 4% on Wednesday after the company announced that its board had approved a $6 billion share repurchase program.

Nations rated AMD a “buy,” pointing out that former President Donald Trump is reportedly planning to roll back restrictions on U.S. chip exports—something he said would be “positive for the entire sector.” He also called AMD the “second-best name” in the space, citing the company’s recent deal with Saudi firm Humain to help build out AI infrastructure, alongside Nvidia.

“If you’re looking to invest in AI, this is a chance to buy at a 35% discount from its 52-week high,” Nations said. While AMD has rallied nearly 25% over the past month, it’s still down more than 2% year-to-date.

AbbVie

Biotech giant AbbVie saw its stock fall over 5% during Wednesday’s session.

Citi downgraded the stock from Buy to Neutral and lowered its price target by $5 to $205 per share, still implying over 15% upside. Analyst Geoff Meacham noted that despite AbbVie’s track record of “consistent beats and raised guidance,” the company’s late-stage pipeline appears weak relative to peers.

“Fundamentals are solid right now,” Meacham wrote in a note to clients, “but as investors increasingly focus on pipeline strength, the impact of quarterly surprises could begin to fade.”

Nations disagreed strongly with that take, calling the downgrade “truly foolish” and reiterating his “buy” rating on AbbVie. “Pipeline matters for every pharma company, but AbbVie keeps beating earnings expectations, raising dividends, and offers a solid 3.5% yield. It’s in a good space,” he said. The stock is down 8% over the past three months.

Tesla

Tesla shares climbed 4% on Wednesday after Reuters, citing sources familiar with the matter, reported that the EV maker will begin shipping components for its Cybercab and Semi truck from China to the U.S. later this month. The report came after the U.S. and China agreed earlier this week to temporarily suspend certain tariffs for 90 days.

The development comes as Tesla grapples with declining sales in China and intensifying competition from local automakers. “I see Tesla as a hold right now,” Nations said. “It’s good that they’re resuming imports from China, but don’t forget: there are still some hefty tariffs on Chinese goods. In about 85 days, those could jump again—maybe even triple.”

Tesla shares surged nearly 26% last week but remain down about 14% during that same period, leaving the stock still in negative territory for the year.

[Compliance Note]

  • All posts by Sellsmart are for informational purposes only. Final investment decisions should be made with careful judgment and at the investor’s own risk.

  • The content of this post may be inaccurate, and any profits or losses resulting from trades are solely the responsibility of the investor.

  • Core16 may hold positions in the stocks mentioned in this post and may buy or sell them at any time.

6
0
0
Comments
0
Please leave a comment first